Dmitriy Zamarin

41PUBLICATIONS
262CO-AUTHORS
NanomedicineMolecular targetsCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Aug 18, 2026
Safety and efficacy of intratumoral MEDI1191, an IL-12 mRNA lipid nanoparticle, plus intravenous durvalumab in patients with advanced solid tumors: a first-in-human study.

|Jun 19, 2026
Advances in immunotherapies in ovarian cancer.

|Apr 13, 2026
Rethinking ovarian cancer III: the past decade and future directions.

Frances R Balkwill, Céline M Laumont, Nikki Burdett

|Feb 26, 2026
Sensitive CAR T cells redefine targetable CD70 expression in solid tumors.

Sophie A Hanina, Tyler Park, Michael Lopez

|Nov 17, 2025
Thrombospondin-1-CD47 signaling contributes to the development of T cell exhaustion in cancer.

Chien-Huan Weng, Anais Assouvie, Lauren Dong

|Oct 01, 2025
Tracking clonal evolution during treatment in ovarian cancer using cell-free DNA.

Marc J Williams, Ignacio Vázquez-García, Grittney Tam

Pageof 7

Frequent Collaborators

11 joint publications

Britta Weigelt

6 joint publications

Sohrab P Shah

6 joint publications

Claire F Friedman

5 joint publications

Michelle Wu